ICLR - ICON Public Limited Company
| Previous Close | 121.22 |
| Open | 119.43 |
| Bid | 110.49 x 100 |
| Ask | 143.00 x 1200 |
| Day's Range | 116.71 - 121.11 |
| 52 Week Range | 76.81 - 124.65 |
| Volume | 277,436 |
| Avg. Volume | 321,809 |
| Market Cap | 6.362B |
| Beta | 0.27 |
| PE Ratio (TTM) | 22.93 |
| EPS (TTM) | 5.13 |
| Earnings Date | May 3, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 128.25 |
Markit•5 days agoSee what the IHS Markit Score report has to say about ICON PLC.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding ICLR totaled $248 million.
- Business Wire•5 days ago
ICON Announces Agreement with Intel Allowing Integration of the Intel® Pharma Analytics Platform for Clinical Trials
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has agreed on preliminary deal terms with Intel Corporation to enable ICON to offer the Intel® Pharma Analytics Platform for use in clinical trials.
- GlobeNewswire•9 days ago
Detailed Research: Economic Perspectives on ICON, Melco Resorts & Entertainment, Kornit Digital, MercadoLibre, Logitech International S.A, and SK Telecom Co. — What Drives Growth in Today's Competitive Landscape
NEW YORK, April 13, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- Thomson Reuters StreetEvents•12 days ago
Edited Transcript of ICLR presentation 8-Mar-17 3:25pm GMT
ICON PLC at Raymond James Institutional Investors Conference
- Business Wire•19 days ago
ICON Announces Launch of Government and Public Health Solutions to Support Global Public Health
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the rebranding of their acquired ClinicalRM division into ICON Government and Public Health Solutions .
- GlobeNewswire•last month
Recent Analysis Shows SMART Global, DBV Technologies S.A, ICON, Adamas Pharmaceuticals, Shenandoah Telecommunications, and Costamare Market Influences — Renewed Outlook, Key Drivers of Growth
NEW YORK, March 14, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
Markit•last monthSee what the IHS Markit Score report has to say about ICON PLC.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding ICLR is favorable, with net inflows of $314 million. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing.
- Simply Wall St.•2 months ago
Is It Time To Buy ICON Public Limited Company (NASDAQ:ICLR)?
ICON Public Limited Company (NASDAQ:ICLR), a life sciences company based in Ireland, saw a double-digit share price rise of over 10% in the past couple of months on the NasdaqGS.Read More...
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of ICLR earnings conference call or presentation 15-Feb-18 2:00pm GMT
Full Year 2017 ICON PLC Earnings Call
- Associated Press•2 months ago
Icon PLC beats 4Q profit forecasts
The Dublin-based company said it had profit of $1.30 per share. Earnings, adjusted for pretax expenses, were $1.43 per share. The results beat Wall Street expectations. The average estimate of 10 analysts ...
- Business Wire•2 months ago
ICON Reports Fourth Quarter and Full Year 2017 Results
ICON plc , a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the fourth quarter and full year ended December 31, 2017.
Markit•3 months agoSee what the IHS Markit Score report has to say about ICON PLC.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding ICLR is favorable, with net inflows of $654 million. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing.
- Business Wire•3 months ago
ICON Issues Financial Guidance for Full Year 2018
ICON plc , a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced its financial guidance for the year ended December 31, 2018.
- Business Wire•3 months ago
ICON Appoints Dr. James Cummings as President of ClinicalRM
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Dr.
- Business Wire•5 months ago
ICON Wins Best Contract Research Organisation at the Annual Scrip Awards 2017
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has won Best Contract Research Organisation – Full-Service Providers at the 2017 Scrip Awards, which took place in London on 29 November.
- Simply Wall St.•5 months ago
Does ICON Public Limited Company’s (ICLR) Past Performance Indicate A Stronger Future?
When ICON Public Limited Company (NASDAQ:ICLR) released its most recent earnings update (30 September 2017), I compared it against two factor: its historical earnings track record, and the performance ofRead More...
- Simply Wall St.•5 months ago
What Do Analysts Think About ICON Public Limited Company’s (ICLR) Future?
Based on the latest analyst predictions, ICON Public Limited Company (NASDAQ:ICLR) is estimated to sizably grow its earnings by 40.34% in the upcoming three years. With the recent EPS beingRead More...
- Business Wire•5 months ago
ICON Launches FIRECREST Pre-Screen to Improve the Speed and Accuracy of Identifying Eligible Patients for Screening
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of FIRECREST Pre-Screen, an innovative digital solution that increases the efficiency and quality of initial patient eligibility assessments.
- Business Wire•5 months ago
ICON Announces Appointment of Ms. Joan Garahy to Board of Directors
ICON plc, global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Ms.
- Business Wire•5 months ago
MediMedia Managed Markets, an ICON Company, Wins Two Gold Industry Awards for Data Analytics and Healthcare Communications
ICON plc, ) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that MediMedia Managed Markets, an ICON company, has received two gold industry awards in recognition of innovative customer solutions.
- Business Wire•5 months ago
Medidata Selected by ICON to Evolve Image Management and Accelerate Research Goals for Sponsors and Sites During Clinical Trials
Medidata , the leading global provider of cloud-based solutions and data analytics for clinical research, and ICON , a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced a new collaboration to enhance the management of medical imaging during drug development research.
- Capital Cube•5 months ago
ICON plc breached its 50 day moving average in a Bearish Manner : ICLR-US : November 13, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ICON plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)
